The content is available as a PDF (108.6 KB).
References
- Dilly S (1994) Granisetron: clinical safety and tolerance. Semin Oncol 23 [Suppl 5]:10–14 [PubMed] [Google Scholar]
- Hesketh PJ, Plagge P, Bryson JC (1992) Single dose ondansteron for the prevention of acute cisplatin-induced emesis: analysis of efficacy and prognostic factors. Colloque INSERM 223:235–236 [Google Scholar]
- Kumar M (1993) Pancreatitis following ifosfamide therapy. Cancer Res Ther Control 3:137–138 [Google Scholar]
- Lieschke GJ, Burgess AW (1992) Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. N Engl J Med 327:28–35 [DOI] [PubMed] [Google Scholar]
- Marty M, Pouillart P, Scholl S, Droz JP, Azab M, Brion N, Pujade-Lauraine E, Paule B, Paes D, Bons J (1990) Comparison of the 5HT3 antagonist ondansteron with high-dose metoclopramide in the control of cisplatin-induced emesis. N Engl J Med 322:816–821 [DOI] [PubMed] [Google Scholar]
- Steer L (1991) Acute pancreatitis. In: Yamada T (ed) Textbook of gastroenterology, vol 2. Lippincott, Philadelphia, pp 1859–1874 [Google Scholar]